Significant Discovery Reveals New Antiviral Properties of Tetra Bio-Pharma’s (OTC: TBPMF) Innovative Drug ARDS-003
Combining ARDS-003 with antiviral drugs significantly decreased viral replication compared to antiviral treatment alone. OTTAWA, ON, June 21, 2021 – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and […]